Tobias Klatte

24PUBLICATIONS
53CO-AUTHORS
Haematological tumoursOther Indigenous studies not elsewhere classifiedCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 19, 2026
Non-significant does not mean uninformative - but poor reporting can be misleading.

Sigrid V Carlsson, Tobias Klatte, Nathan Papa

|Jan 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results.

Pietro Scilipoti, Mattia Longoni, Mario de Angelis

Pageof 4